Literature DB >> 27388930

CDC's Response to the 2014-2016 Ebola Epidemic - Guinea, Liberia, and Sierra Leone.

Benjamin A Dahl1, Michael H Kinzer, Pratima L Raghunathan, Athalia Christie, Kevin M De Cock, Frank Mahoney, Sarah D Bennett, Sara Hersey, Oliver W Morgan.   

Abstract

CDC's response to the 2014-2016 Ebola virus disease (Ebola) epidemic in West Africa was the largest in the agency's history and occurred in a geographic area where CDC had little operational presence. Approximately 1,450 CDC responders were deployed to Guinea, Liberia, and Sierra Leone since the start of the response in July 2014 to the end of the response at the end of March 2016, including 455 persons with repeat deployments. The responses undertaken in each country shared some similarities but also required unique strategies specific to individual country needs. The size and duration of the response challenged CDC in several ways, particularly with regard to staffing. The lessons learned from this epidemic will strengthen CDC's ability to respond to future public health emergencies. These lessons include the importance of ongoing partnerships with ministries of health in resource-limited countries and regions, a cadre of trained CDC staff who are ready to be deployed, and development of ongoing working relationships with U.S. government agencies and other multilateral and nongovernment organizations that deploy for international public health emergencies. CDC's establishment of a Global Rapid Response Team in June 2015 is anticipated to meet some of these challenges. The activities summarized in this report would not have been possible without collaboration with many U.S. and international partners (http://www.cdc.gov/vhf/ebola/outbreaks/2014-west-africa/partners.html).

Entities:  

Mesh:

Year:  2016        PMID: 27388930     DOI: 10.15585/mmwr.su6503a3

Source DB:  PubMed          Journal:  MMWR Suppl        ISSN: 2380-8942


  13 in total

1.  Comment: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Authors:  Anne Schuchat; Jane F Seward; Susan T Goldstein; Barbara E Mahon
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

2.  Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Authors:  Muhammad-Abbas Conteh; Susan T Goldstein; Haja R Wurie; Jane Gidudu; Durodami Radcliffe Lisk; Rosalind J Carter; Jane F Seward; Lee M Hampton; David Wang; Lauren E Andersen; Melissa Arvay; Stephanie J Schrag; Peter Dawson; Augustin E Fombah; Carey R Petrie; Daniel R Feikin; James B W Russell; Robert Lindblad; S A S Kargbo; Mohamed Samai; Barbara E Mahon
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

3.  Utilizing Nurses to Staff an Ebola Vaccine Clinical Trial in Sierra Leone during the Ebola Outbreak.

Authors:  Joseph Edem-Hotah; Wendi McDonald; Patricia M Abu; Elizabeth T Luman; Rosalind J Carter; Ayesha Koker; Susan T Goldstein
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

4.  Distinguishing epidemiological features of the 2013-2016 West Africa Ebola virus disease outbreak.

Authors:  James M Shultz; Zelde Espinel; Maria Espinola; Andreas Rechkemmer
Journal:  Disaster Health       Date:  2016-08-25

5.  Contact tracing performance during the Ebola virus disease outbreak in Kenema district, Sierra Leone.

Authors:  Mikiko Senga; Alpha Koi; Lina Moses; Nadia Wauquier; Philippe Barboza; Maria Dolores Fernandez-Garcia; Etsub Engedashet; Fredson Kuti-George; Aychiluhim Damtew Mitiku; Mohamed Vandi; David Kargbo; Pierre Formenty; Stephane Hugonnet; Eric Bertherat; Christopher Lane
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-26       Impact factor: 6.237

6.  Recrudescence of Ebola virus disease outbreak in West Africa, 2014-2016.

Authors:  Hyojung Lee; Hiroshi Nishiura
Journal:  Int J Infect Dis       Date:  2017-09-20       Impact factor: 3.623

7.  Addressing Operational Challenges Faced by COVID-19 Public Health Rapid Response Teams in Non-United States Settings.

Authors:  Puneet Anantharam; Adela Hoffman; Michelle Noonan; Dante Bugli; Laura Pechta; Jennifer Bornemann; Kerton R Victory; Ashley L Greiner
Journal:  Disaster Med Public Health Prep       Date:  2020-12-22       Impact factor: 1.385

8.  Can we do better? A guide to pandemics - some Dos and Don'ts for the next one.

Authors:  Julian W Tang; Kin On Kwok; Tze Ping Loh; Chun Kiat Lee; Jean-Michel Heraud; Stephanie J Dancer
Journal:  J Infect       Date:  2021-04-22       Impact factor: 6.072

9.  Public health response to COVID-19 in selected countries - Hits and misses.

Authors:  Rama Shankar Rath; Ayush Lohiya; Farhad Ahamed; Jeyashree Kathiresan; Rizwan Abdulkader Suliankatchi
Journal:  J Family Med Prim Care       Date:  2020-11-30

Review 10.  Establishment of CDC Global Rapid Response Team to Ensure Global Health Security.

Authors:  Tasha Stehling-Ariza; Adrienne Lefevre; Dinorah Calles; Kpandja Djawe; Richard Garfield; Michael Gerber; Margherita Ghiselli; Coralie Giese; Ashley L Greiner; Adela Hoffman; Leigh Ann Miller; Lisa Moorhouse; Carlos Navarro-Colorado; James Walsh; Dante Bugli; Cyrus Shahpar
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.